Is the Michael Jackson biopic already in trouble

The Michael Jackson biopic, simply titled Michael, has fans buzzing and skeptics raising eyebrows as it hurtles toward an April 2026 release. Directed by Antoine Fuqua and starring Jaafar Jackson as the King of Pop, the film promises a glossy look at his rise from Jackson 5 prodigy to solo superstar. But with multiple delays, reshoots, legal snags, and family drama, questions swirl: is this estate-backed project already stumbling before it hits theaters?

Recent trailer drops shattered records, pulling in over 116 million views in 24 hours, yet whispers from Hollywood insiders suggest deeper troubles. From budget overruns to script rewrites dodging abuse allegations, the production's path feels rocky. As nostalgia clashes with post-Leaving Neverland scrutiny, this biopic walks a tightrope between celebration and controversy.

Delays pile up

The Michael Jackson biopic's release has shifted three times, from April 2025 to October 2025, and now to April 18, 2026. Lionsgate cited the need for premium format screenings and additional polishing as reasons. This pattern echoes other high-profile films facing post-production hurdles, but here it fuels speculation about underlying issues.

Principal photography wrapped in May 2024, yet the timeline extensions point to more than just scheduling tweaks. Industry watchers note that such delays often signal creative or legal roadblocks. For a $155 million project, these postponements raise stakes for investors expecting a box-office juggernaut.

Early buzz positioned the film as a potential Bohemian Rhapsody-style hit, tapping into Jackson's enduring legacy. However, repeated pushbacks have tempered enthusiasm, with some fans voicing frustration online. The latest date sets up a spring 2026 rollout, aligning with awards chatter but risking further slippage.

Reshoots cause stir

In June 2025, the production returned for 22 days of reshoots, focusing on the third act. This came after discovering a 1993 settlement with the Chandler family barred depicting them in the script. Originally, the film portrayed the accusers as opportunistic, prompting a scramble to rewrite and refilm key scenes.

Director Antoine Fuqua downplayed the changes, emphasizing the film's commitment to Jackson's story. Yet, reports from Puck suggest producers were caught off-guard by the legal restriction. This oversight highlights the challenges of navigating Jackson's complex history in a biopic format.

Reshoots aren't uncommon in big-budget films, but here they underscore the delicate balance of honoring the icon while sidestepping controversy. The additional work has ballooned costs, with whispers of a potential two-film split to cover more ground. For now, the team aims to refine the narrative without alienating audiences.

Legal snags surface

The Chandler settlement's prohibition on dramatizing the 1993 allegations forced major script alterations. Estate lawyers had overlooked this clause, leading to hurried revisions. This legal wrinkle exemplifies the minefield of portraying Jackson's life amid unresolved claims.

Beyond the Chandlers, broader concerns linger about how the film addresses abuse accusations. The estate, which co-produces, denies all allegations, shaping a narrative that focuses on triumphs. Critics argue this approach risks whitewashing, especially post-2019's Leaving Neverland documentary.

Legal experts note that such constraints could limit artistic freedom, potentially resulting in a sanitized version. As the film nears release, these issues may invite lawsuits or public backlash. The production's handling will test Hollywood's appetite for controversial biopics.

Family feuds erupt

Paris Jackson publicly criticized an early script draft in September 2025, calling parts "dishonest" and pandering to fans' fantasies. She provided notes but felt ignored. The estate dismissed her complaints as a "profound waste of time," highlighting deep rifts within the family.

Reports of tension at a family screening involving over 60 relatives surfaced, with Janet Jackson allegedly clashing with brother Jermaine. Taj Jackson denied these claims as false, but the discord adds to the drama. Such internal conflicts mirror the Jackson family's long history of public spats.

These disputes could impact promotion, as family members like Jermaine support the project while others distance themselves. For a biopic rooted in family dynamics, this irony underscores authenticity debates. Moving forward, reconciling these views might prove essential for cohesive marketing.

Estate controls narrative

The Jackson estate's involvement ensures a pro-Michael framing, approving scripts and access to archives. This control has drawn criticism for potentially glossing over darker aspects. Supporters see it as protecting his legacy against unproven claims.

Comparisons to Bohemian Rhapsody abound, where estate input led to a crowd-pleasing hit despite controversies. Here, the strategy bets on nostalgia outweighing skepticism. Yet, with Leaving Neverland's impact, some audiences demand a fuller reckoning.

Estate executors remain firm, viewing the biopic as a celebration of artistry. This stance influences everything from casting to editing, aiming for a triumphant tale. As release approaches, it will reveal if this vision resonates or reignites debates.

Trailer generates hype

The first teaser trailer amassed 116 million views in 24 hours, setting a Lionsgate record and surpassing Taylor Swift's Eras Tour promo. It showcases Jaafar Jackson's uncanny mimicry of Michael's moves and voice, focusing on family bonds and iconic performances.

Full trailers emphasize early career highs, from Jackson 5 days to solo breakthroughs. This glossy presentation has thrilled fans, sparking social media buzz. Industry analysts see it as a savvy PR move amid production woes.

Despite the record-breaking response, some viewers critique the trailer's avoidance of controversies. It positions the film as an uplifting biopic, betting on Jackson's musical genius to draw crowds. Early indicators suggest strong box-office potential if troubles subside.

Abuse claims linger

The Michael Jackson biopic treads carefully around child abuse allegations, with the estate denying them outright. Post-Leaving Neverland, divisions persist: fans defend Jackson's innocence, while others seek accountability. The film's approach has sparked criticism for possible omission.

Reshoots addressed legal barriers but left questions about how accusations are portrayed. Victims' advocates worry the narrative may downplay serious claims, prioritizing entertainment over truth. This sober reality contrasts with the project's celebratory tone.

Empathy for those who came forward remains crucial, as their stories highlight broader issues of power and exploitation in fame. The biopic's handling could influence public perception, potentially reopening wounds for survivors. Hollywood must navigate this with sensitivity.

Casting draws praise

Jaafar Jackson, Michael's nephew, stars in his acting debut, praised for his natural emulation of the icon's mannerisms. Director Fuqua highlighted the "spiritual connection" and camera chemistry. This family tie adds authenticity to the portrayal.

Critics and fans alike note Jaafar's vocal and dance resemblances, captured in trailers. His involvement stems from Jermaine Jackson's support, blending legacy with fresh talent. Early reactions from family screenings were enthusiastic, despite reported tensions.

While the casting boosts insider appeal, it also entangles the film in family politics. Jaafar's performance could be a highlight, drawing on real-life insights. As debates swirl, his role embodies the biopic's blend of homage and controversy.

Budget concerns grow

With a $155 million budget, overruns from reshoots and delays strain finances. Lionsgate's investment hinges on global appeal, targeting Jackson's massive fanbase. Comparisons to music biopics like Rocketman suggest potential returns, but risks abound.

Studio politics play in, with whispers of a two-part film to maximize revenue. This strategy could address narrative scope but adds complexity. Executives remain optimistic, citing trailer success as a positive sign.

Financial pressures underscore the high stakes: a flop could dent Lionsgate's slate, while success might redefine Jackson's cultural footprint. As costs mount, the team focuses on delivering a polished product worthy of the icon's stature.

What lies ahead

As the Michael Jackson biopic navigates these choppy waters, its April 2026 release looms as a litmus test for Hollywood's handling of flawed icons. Balancing nostalgia with nuance could yield a cultural touchstone, or deepen divides—either way, it keeps Jackson's complex legacy in the spotlight, inviting fresh conversations about fame, truth, and redemption.